As the same as the previous study has shown, YRDC was highly expressed in lung cancer and hepatocellular carcinoma, and the knockdown and overexpression model validated the expression and protein level of YRDC in cell lines [9, 10]. The gene discussed is YRDC; the disease is lung carcinoma.